SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Arthur Klausner to speak at the 13th Annual Drug Discovery & Development of Innovative Therapeutics (DDT) in Boston, MA
News | 08. 04. 2008